Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Coriell Institute to offer PluriTest
March 2016
SHARING OPTIONS:

CAMDEN, N.J.—The Coriell Institute for Medical Research recently announced that it had in-licensed PluriTest, an animal-free bioinformatics assay for determining the pluripotency of human induced pluripotent stem cells. The test uses microarray technology to identify genes that are active in normal human embryonic and induced pluripotent stem cells and non-pluripotent cells in order to generate a detailed molecular model of a normal pluripotent stem cell line, and can determine whether a cell is capable of diverse differentiation.
 
“This is a field of interest that has been marked by a tremendous amount of growth and progress in a relatively short span of time,” said Dr. Michael Christman, president and CEO of Coriell Institute. “As scientists increasingly rely on these powerful assets to drive disease studies, it’s imperative that hiPSC lines are of a high and consistent grade. Partnering with Drs. Loring and Müller and facilitating access to this innovative assay ensures those benchmarks of quality are met.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.